✦ LIBER ✦

Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

✍ Scribed by Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide Oshita; Hideki Hagiwara; Eiji Mita; Toshifumi Ito; Yoshiaki Inui; Hiroyuki Fukui; Taizo Hijioka; Kazuhiro Katayama; Shinji Tamura; Harumasa Yoshihara; Atsuo Inoue; Yasuharu Imai; Eijiro Hayashi; Michio Kato; Atsushi Hosui; Takuya Miyagi; Hisashi Ishida; Yuichi Yoshida; Tomohide Tatsumi; Shinichi Kiso; Tatsuya Kanto; Akinori Kasahara; Tetsuo Takehara; Norio Hayashi

Publisher: Springer Japan
Year: 2011
Tongue: English
Weight: 297 KB
Volume: 46
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-011-0409-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment of patients with chronic hep

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine

✍ Rudolf E Stauber; Harald Hofer; Franz Hackl; Kurt Schüze; Christian Datz; Karin 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 738 KB

Efficacy of pegylated interferon plus ri

Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case–control study

✍ Naoki Hiramatsu; Yuko Inoue; Tsugiko Oze; Nao Kurashige; Takayuki Yakushijin; Ki 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 209 KB

Retinopathy in hepatitis C patients due

Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin

✍ Ei Tae Kim; Lee Hoo Kim; Jung Il Lee; Hee Seung Chin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a